GNPX insider filings
Genprex, Inc. — 30 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-04-15. Screen GNPX transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for GNPX between 2026-07-10 and 2026-10-08. The table below lists the most recent filings on record.
Recent insider filings — Genprex, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-04-15 | 4 | LONGNECKER BRENT M — Director | Sale (S): 8 @ $1.23 · Sale (S): 10 @ $1.23 | EDGAR |
| 2026-02-27 | 4 | Berger Mark Stanley — Chief Medical Officer | Tax withholding (F): 7,168 @ $2 | EDGAR |
| 2026-02-27 | 4 | Confer Ryan M. — President, CEO and CFO, Director | Tax withholding (F): 9,330 @ $2 | EDGAR |
| 2025-12-23 | 4 | Moreno Toscano Jose Antonio — Director | Grant/award (A): 9,000 @ $0 | EDGAR |
| 2025-12-23 | 4 | Berger Mark Stanley — Chief Medical Officer | Grant/award (A): 28,500 @ $0 | EDGAR |
| 2025-12-23 | 4 | Confer Ryan M. — President, CEO and CFO, Director | Grant/award (A): 45,000 @ $0 | EDGAR |
| 2025-12-23 | 4 | Wilson William R Jr. — Director | Grant/award (A): 9,000 @ $0 | EDGAR |
| 2025-12-23 | 4 | LONGNECKER BRENT M — Director | Grant/award (A): 9,000 @ $0 | EDGAR |
| 2025-07-01 | 4 | Berger Mark Stanley — Chief Medical Officer | Tax withholding (F): 4,500 @ $0.23 | EDGAR |
| 2025-07-01 | 4 | Confer Ryan M. — President, CEO and CFO, Director | Tax withholding (F): 5,775 @ $0.23 | EDGAR |
| 2025-02-19 | 4 | Berger Mark Stanley — Chief Medical Officer | Tax withholding (F): 585 @ $0.41 | EDGAR |
| 2025-02-19 | 4 | Confer Ryan M. — President, CEO and CFO, Director | Tax withholding (F): 395 @ $0.41 | EDGAR |
| 2024-12-06 | 4 | Moreno Toscano Jose Antonio — Director | Grant/award (A): 4,750 @ $0 | EDGAR |
| 2024-12-06 | 4 | Wilson William R Jr. — Director | Grant/award (A): 4,750 @ $0 | EDGAR |
| 2024-12-06 | 4 | Confer Ryan M. — President, CEO and CFO, Director | Grant/award (A): 29,375 @ $0 | EDGAR |
| 2024-12-06 | 4 | Berger Mark Stanley — Chief Medical Officer | Grant/award (A): 18,250 @ $0 | EDGAR |
| 2024-12-06 | 4 | LONGNECKER BRENT M — Director | Grant/award (A): 4,750 @ $0 | EDGAR |
| 2024-02-21 | 4 | Berger Mark Stanley — Chief Medical Officer | Tax withholding (F): 1,319 @ $4.40 | EDGAR |
| 2024-02-21 | 4 | Varner John Rodney — Chairman, President and CEO, Director | Tax withholding (F): 2,642 @ $4.40 | EDGAR |
| 2024-02-21 | 4 | Confer Ryan M. — Chief Financial Officer | Tax withholding (F): 1,126 @ $4.40 | EDGAR |
| 2023-06-29 | 4 | Moreno Toscano Jose Antonio — Director | Grant/award (A): 123,795 @ $0 | EDGAR |
| 2023-06-29 | 4 | Wilson William R Jr. — Director | Grant/award (A): 123,795 @ $0 | EDGAR |
| 2023-06-29 | 4 | LONGNECKER BRENT M — Director | Grant/award (A): 123,795 @ $0 | EDGAR |
| 2023-04-24 | 4 | Varner John Rodney — Chairman, President and CEO, Director | Purchase (P): 19,000 @ $1.05 | EDGAR |
| 2023-04-24 | 4 | VACZY CATHERINE M — EVP GC Chief Strategy Officer | Purchase (P): 20,000 @ $1.07 | EDGAR |
| 2023-02-22 | 4 | Varner John Rodney — President & CEO, Director | Grant/award (A): 625,000 @ $0 | EDGAR |
| 2023-02-22 | 4 | Berger Mark Stanley — Chief Medical Officer | Grant/award (A): 245,000 @ $0 | EDGAR |
| 2023-02-22 | 4 | Kumar Hermant — Chief Mfgr & Tech Officer | Grant/award (A): 200,000 @ $0 | EDGAR |
| 2023-02-22 | 4 | Confer Ryan M. — Chief Financial Officer | Grant/award (A): 245,000 @ $0 | EDGAR |
| 2023-02-22 | 4 | VACZY CATHERINE M — EVP GC Chief Strategy Officer | Grant/award (A): 245,000 @ $0 | EDGAR |
Recent 8-K events — Genprex, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-18 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-05 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-03 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-30 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-14 | 8-K | 3.03 — Material Modification to Rights of Security Holders 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-22 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-18 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-12 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-26 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-14 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=GNPX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →